Approval · Notice of Compliance 3586 · 2003
NU-SIMVASTATIN: Notice of Compliance 3586
Issued January 15, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3586
- Date
- January 15, 2003
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Lipid metabolism regulator
- Canadian reference product
- ZOCOR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-SIMVASTATIN | 02247072 | Cancelled Post Market |
| NU-SIMVASTATIN | 02247075 | Cancelled Post Market |
| NU-SIMVASTATIN | 02247076 | Cancelled Post Market |
| NU-SIMVASTATIN | 02247077 | Cancelled Post Market |
| NU-SIMVASTATIN | 02247078 | Cancelled Post Market |
Medicinal ingredients
- SIMVASTATIN 5 MG per TAB
- SIMVASTATIN 10 MG per TAB
- SIMVASTATIN 20 MG per TAB
- SIMVASTATIN 40 MG per TAB
- SIMVASTATIN 80 MG per TAB